カテゴリ： 世界, 医療/バイオ, Market Monitor Global

外陰部痛管理のグローバル市場展望 2023年-2029年：経口、皮下注射

■ 英語タイトル：Vulvodynia Pain Management Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12467）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12467
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：68
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[外陰部痛管理のグローバル市場展望 2023年-2029年：経口、皮下注射]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の外陰部痛管理市場規模と予測を収録しています。・世界の外陰部痛管理市場：売上、2018年-2023年、2024年-2029年
・世界の外陰部痛管理市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の外陰部痛管理市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

外陰部痛管理のグローバル主要企業は、Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、外陰部痛管理のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の外陰部痛管理市場：タイプ別、2018年-2023年、2024年-2029年
世界の外陰部痛管理市場：タイプ別市場シェア、2022年
・経口、皮下注射

世界の外陰部痛管理市場：用途別、2018年-2023年、2024年-2029年
世界の外陰部痛管理市場：用途別市場シェア、2022年
・病院、専門診療所、その他

世界の外陰部痛管理市場：地域・国別、2018年-2023年、2024年-2029年
世界の外陰部痛管理市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における外陰部痛管理のグローバル売上、2018年-2023年
・主要企業における外陰部痛管理のグローバル売上シェア、2022年
・主要企業における外陰部痛管理のグローバル販売量、2018年-2023年
・主要企業における外陰部痛管理のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc.

*************************************************************

・調査・分析レポートの概要
外陰部痛管理市場の定義
市場セグメント
世界の外陰部痛管理市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の外陰部痛管理市場規模
世界の外陰部痛管理市場規模：2022年 VS 2029年
世界の外陰部痛管理市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの外陰部痛管理の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の外陰部痛管理製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口、皮下注射
外陰部痛管理のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門診療所、その他
外陰部痛管理の用途別グローバル売上・予測

・地域別市場分析
地域別外陰部痛管理市場規模 2022年と2029年
地域別外陰部痛管理売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Taro Pharmaceuticals U.S.A., Inc.、 Teva Pharmaceutical Industries Ltd.、 Acura Pharmaceuticals Inc.、 Purdue Pharma LP、 Alvogen Inc.、 Amneal Pharmaceuticals、 Mallinckrodt Pharmaceuticals、 Lupin Pharmaceuticals、 Alembic Pharmaceuticals、 Merck & Co., Inc.
...

This research report provides a comprehensive analysis of the Vulvodynia Pain Management market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vulvodynia Pain Management market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vulvodynia Pain Management, challenges faced by the industry, and potential opportunities for market players.
The global Vulvodynia Pain Management market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vulvodynia Pain Management market presents opportunities for various stakeholders, including Hospital, Specialty Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vulvodynia Pain Management market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vulvodynia Pain Management market was valued at US$ 5289.7 million in 2022 and is projected to reach US$ 8058 million by 2029, at a CAGR of 6.6% during the forecast period.
Tailoring treatment plans to the specific needs and symptoms of each individual with vulvodynia continues to be a prominent trend. Advances in diagnostic techniques and better understanding of the subtypes of vulvodynia may lead to more precise and individualized treatment strategies.
Key Features:
The research report on the Vulvodynia Pain Management market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vulvodynia Pain Management market.
Market Overview: The report provides a comprehensive overview of the Vulvodynia Pain Management market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oral, Injection), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vulvodynia Pain Management market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vulvodynia Pain Management market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vulvodynia Pain Management market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vulvodynia Pain Management market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vulvodynia Pain Management market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vulvodynia Pain Management market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vulvodynia Pain Management, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vulvodynia Pain Management market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vulvodynia Pain Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Specialty Clinic
Others
Global Vulvodynia Pain Management Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Taro Pharmaceuticals U.S.A., Inc.
Teva Pharmaceutical Industries Ltd.
Acura Pharmaceuticals Inc.
Purdue Pharma LP
Alvogen Inc.
Amneal Pharmaceuticals
Mallinckrodt Pharmaceuticals
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Merck & Co., Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vulvodynia Pain Management, market overview.
Chapter 2: Global Vulvodynia Pain Management market size in revenue.
Chapter 3: Detailed analysis of Vulvodynia Pain Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vulvodynia Pain Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Vulvodynia Pain Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vulvodynia Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vulvodynia Pain Management Overall Market Size
2.1 Global Vulvodynia Pain Management Market Size: 2022 VS 2029
2.2 Global Vulvodynia Pain Management Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vulvodynia Pain Management Players in Global Market
3.2 Top Global Vulvodynia Pain Management Companies Ranked by Revenue
3.3 Global Vulvodynia Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Vulvodynia Pain Management Companies in Global Market, by Revenue in 2022
3.5 Global Companies Vulvodynia Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vulvodynia Pain Management Players in Global Market
3.6.1 List of Global Tier 1 Vulvodynia Pain Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Vulvodynia Pain Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Vulvodynia Pain Management Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.2 By Type – Global Vulvodynia Pain Management Revenue & Forecasts
4.2.1 By Type – Global Vulvodynia Pain Management Revenue, 2018-2023
4.2.2 By Type – Global Vulvodynia Pain Management Revenue, 2024-2029
4.2.3 By Type – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vulvodynia Pain Management Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application – Global Vulvodynia Pain Management Revenue & Forecasts
5.2.1 By Application – Global Vulvodynia Pain Management Revenue, 2018-2023
5.2.2 By Application – Global Vulvodynia Pain Management Revenue, 2024-2029
5.2.3 By Application – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Vulvodynia Pain Management Market Size, 2022 & 2029
6.2 By Region – Global Vulvodynia Pain Management Revenue & Forecasts
6.2.1 By Region – Global Vulvodynia Pain Management Revenue, 2018-2023
6.2.2 By Region – Global Vulvodynia Pain Management Revenue, 2024-2029
6.2.3 By Region – Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Vulvodynia Pain Management Revenue, 2018-2029
6.3.2 US Vulvodynia Pain Management Market Size, 2018-2029
6.3.3 Canada Vulvodynia Pain Management Market Size, 2018-2029
6.3.4 Mexico Vulvodynia Pain Management Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Vulvodynia Pain Management Revenue, 2018-2029
6.4.2 Germany Vulvodynia Pain Management Market Size, 2018-2029
6.4.3 France Vulvodynia Pain Management Market Size, 2018-2029
6.4.4 U.K. Vulvodynia Pain Management Market Size, 2018-2029
6.4.5 Italy Vulvodynia Pain Management Market Size, 2018-2029
6.4.6 Russia Vulvodynia Pain Management Market Size, 2018-2029
6.4.7 Nordic Countries Vulvodynia Pain Management Market Size, 2018-2029
6.4.8 Benelux Vulvodynia Pain Management Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Vulvodynia Pain Management Revenue, 2018-2029
6.5.2 China Vulvodynia Pain Management Market Size, 2018-2029
6.5.3 Japan Vulvodynia Pain Management Market Size, 2018-2029
6.5.4 South Korea Vulvodynia Pain Management Market Size, 2018-2029
6.5.5 Southeast Asia Vulvodynia Pain Management Market Size, 2018-2029
6.5.6 India Vulvodynia Pain Management Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Vulvodynia Pain Management Revenue, 2018-2029
6.6.2 Brazil Vulvodynia Pain Management Market Size, 2018-2029
6.6.3 Argentina Vulvodynia Pain Management Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Vulvodynia Pain Management Revenue, 2018-2029
6.7.2 Turkey Vulvodynia Pain Management Market Size, 2018-2029
6.7.3 Israel Vulvodynia Pain Management Market Size, 2018-2029
6.7.4 Saudi Arabia Vulvodynia Pain Management Market Size, 2018-2029
6.7.5 UAE Vulvodynia Pain Management Market Size, 2018-2029
7 Vulvodynia Pain Management Companies Profiles
7.1 Taro Pharmaceuticals U.S.A., Inc.
7.1.1 Taro Pharmaceuticals U.S.A., Inc. Company Summary
7.1.2 Taro Pharmaceuticals U.S.A., Inc. Business Overview
7.1.3 Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Major Product Offerings
7.1.4 Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.1.5 Taro Pharmaceuticals U.S.A., Inc. Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.3 Acura Pharmaceuticals Inc.
7.3.1 Acura Pharmaceuticals Inc. Company Summary
7.3.2 Acura Pharmaceuticals Inc. Business Overview
7.3.3 Acura Pharmaceuticals Inc. Vulvodynia Pain Management Major Product Offerings
7.3.4 Acura Pharmaceuticals Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.3.5 Acura Pharmaceuticals Inc. Key News & Latest Developments
7.4 Purdue Pharma LP
7.4.1 Purdue Pharma LP Company Summary
7.4.2 Purdue Pharma LP Business Overview
7.4.3 Purdue Pharma LP Vulvodynia Pain Management Major Product Offerings
7.4.4 Purdue Pharma LP Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.4.5 Purdue Pharma LP Key News & Latest Developments
7.5 Alvogen Inc.
7.5.1 Alvogen Inc. Company Summary
7.5.2 Alvogen Inc. Business Overview
7.5.3 Alvogen Inc. Vulvodynia Pain Management Major Product Offerings
7.5.4 Alvogen Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.5.5 Alvogen Inc. Key News & Latest Developments
7.6 Amneal Pharmaceuticals
7.6.1 Amneal Pharmaceuticals Company Summary
7.6.2 Amneal Pharmaceuticals Business Overview
7.6.3 Amneal Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.6.4 Amneal Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.6.5 Amneal Pharmaceuticals Key News & Latest Developments
7.7 Mallinckrodt Pharmaceuticals
7.7.1 Mallinckrodt Pharmaceuticals Company Summary
7.7.2 Mallinckrodt Pharmaceuticals Business Overview
7.7.3 Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.7.4 Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.7.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Summary
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.8.4 Lupin Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.8.5 Lupin Pharmaceuticals Key News & Latest Developments
7.9 Alembic Pharmaceuticals
7.9.1 Alembic Pharmaceuticals Company Summary
7.9.2 Alembic Pharmaceuticals Business Overview
7.9.3 Alembic Pharmaceuticals Vulvodynia Pain Management Major Product Offerings
7.9.4 Alembic Pharmaceuticals Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.9.5 Alembic Pharmaceuticals Key News & Latest Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Company Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Vulvodynia Pain Management Major Product Offerings
7.10.4 Merck & Co., Inc. Vulvodynia Pain Management Revenue in Global Market (2018-2023)
7.10.5 Merck & Co., Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Vulvodynia Pain Management Market Opportunities & Trends in Global Market
Table 2. Vulvodynia Pain Management Market Drivers in Global Market
Table 3. Vulvodynia Pain Management Market Restraints in Global Market
Table 4. Key Players of Vulvodynia Pain Management in Global Market
Table 5. Top Vulvodynia Pain Management Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Vulvodynia Pain Management Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Vulvodynia Pain Management Revenue Share by Companies, 2018-2023
Table 8. Global Companies Vulvodynia Pain Management Product Type
Table 9. List of Global Tier 1 Vulvodynia Pain Management Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vulvodynia Pain Management Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Vulvodynia Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Vulvodynia Pain Management Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Vulvodynia Pain Management Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Vulvodynia Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Vulvodynia Pain Management Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Vulvodynia Pain Management Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Vulvodynia Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Vulvodynia Pain Management Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Vulvodynia Pain Management Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Vulvodynia Pain Management Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Vulvodynia Pain Management Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Vulvodynia Pain Management Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Vulvodynia Pain Management Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Vulvodynia Pain Management Revenue, (US$, Mn), 2024-2029
Table 30. Taro Pharmaceuticals U.S.A., Inc. Company Summary
Table 31. Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Product Offerings
Table 32. Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 33. Taro Pharmaceuticals U.S.A., Inc. Key News & Latest Developments
Table 34. Teva Pharmaceutical Industries Ltd. Company Summary
Table 35. Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Product Offerings
Table 36. Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 38. Acura Pharmaceuticals Inc. Company Summary
Table 39. Acura Pharmaceuticals Inc. Vulvodynia Pain Management Product Offerings
Table 40. Acura Pharmaceuticals Inc. Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 41. Acura Pharmaceuticals Inc. Key News & Latest Developments
Table 42. Purdue Pharma LP Company Summary
Table 43. Purdue Pharma LP Vulvodynia Pain Management Product Offerings
Table 44. Purdue Pharma LP Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 45. Purdue Pharma LP Key News & Latest Developments
Table 46. Alvogen Inc. Company Summary
Table 47. Alvogen Inc. Vulvodynia Pain Management Product Offerings
Table 48. Alvogen Inc. Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 49. Alvogen Inc. Key News & Latest Developments
Table 50. Amneal Pharmaceuticals Company Summary
Table 51. Amneal Pharmaceuticals Vulvodynia Pain Management Product Offerings
Table 52. Amneal Pharmaceuticals Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 53. Amneal Pharmaceuticals Key News & Latest Developments
Table 54. Mallinckrodt Pharmaceuticals Company Summary
Table 55. Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Product Offerings
Table 56. Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 57. Mallinckrodt Pharmaceuticals Key News & Latest Developments
Table 58. Lupin Pharmaceuticals Company Summary
Table 59. Lupin Pharmaceuticals Vulvodynia Pain Management Product Offerings
Table 60. Lupin Pharmaceuticals Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 61. Lupin Pharmaceuticals Key News & Latest Developments
Table 62. Alembic Pharmaceuticals Company Summary
Table 63. Alembic Pharmaceuticals Vulvodynia Pain Management Product Offerings
Table 64. Alembic Pharmaceuticals Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 65. Alembic Pharmaceuticals Key News & Latest Developments
Table 66. Merck & Co., Inc. Company Summary
Table 67. Merck & Co., Inc. Vulvodynia Pain Management Product Offerings
Table 68. Merck & Co., Inc. Vulvodynia Pain Management Revenue (US$, Mn) & (2018-2023)
Table 69. Merck & Co., Inc. Key News & Latest Developments
List of Figures
Figure 1. Vulvodynia Pain Management Segment by Type in 2022
Figure 2. Vulvodynia Pain Management Segment by Application in 2022
Figure 3. Global Vulvodynia Pain Management Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vulvodynia Pain Management Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Vulvodynia Pain Management Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vulvodynia Pain Management Revenue in 2022
Figure 8. By Type - Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 9. By Application - Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 10. By Type - Global Vulvodynia Pain Management Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 12. By Application - Global Vulvodynia Pain Management Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 14. By Region - Global Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 15. By Country - North America Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 16. US Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 20. Germany Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 21. France Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 28. China Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 32. India Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 34. Brazil Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Vulvodynia Pain Management Revenue Market Share, 2018-2029
Figure 37. Turkey Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Vulvodynia Pain Management Revenue, (US$, Mn), 2018-2029
Figure 41. Taro Pharmaceuticals U.S.A., Inc. Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Industries Ltd. Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Acura Pharmaceuticals Inc. Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Purdue Pharma LP Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Alvogen Inc. Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amneal Pharmaceuticals Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mallinckrodt Pharmaceuticals Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lupin Pharmaceuticals Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Alembic Pharmaceuticals Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck & Co., Inc. Vulvodynia Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 可換性バイオシミラーヒュミラ医薬品のグローバル市場展望 2023年-2029年：皮下注射、静脈注射
  • 閉経後骨粗鬆症治療薬のグローバル市場展望 2023年-2029年：経口式、皮下注射、静脈注射、その他
  • 好酸球性喘息治療薬の世界市場2023年：静脈内注射、皮下注射
  • 疼痛管理用治療薬のグローバル市場展望 2023年-2029年：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他
  • 鎮痛薬のグローバル市場展望 2023年-2029年：ジェネリック製品オピオイド、ブランド製品オピオイド、NSAID、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12467 )"外陰部痛管理のグローバル市場展望 2023年-2029年：経口、皮下注射" (英文：Vulvodynia Pain Management Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。